Roderick R. McInnes is the Director of the Lady Davis Institute of the Jewish General Hospital, Canada Research Chair in Neurogenetics, and Professor of Genetics and of Biochemistry at McGill University, where he has succeeded Charles Scriver as the Alva Chair in Human Genetics. Until recently, he was a University Professor of the University of Toronto and Senior Scientist at the Hospital for Sick Children. Dr. McInnes received his undergraduate and medical degrees from Dalhousie University, and his Ph.D. from McGill. Previously he was the Head of the Program in Developmental Biology at the Research Institute of the Hospital for Sick Children, an International Research Scholar of the Howard Hughes Medical Institute and, from 2000-2010, the inaugural Scientific Director of the Institute of Genetics of CIHR. He has made important contributions to the understanding of the molecular basis of retinal and eye development, and to the identification of genes and processes associated with inherited retinal degenerations. Recently, he and collaborators identified an important protein, Neto1, required for learning and memory, and established that it is possible to correct an inherited learning defect in mice with a drug, a finding with important implications for human learning disability. He is a coauthor of the 5th, 6th and 7th editions of Thompson and Thompson’s Genetics in Medicine, and of the CIHR Guidebook for New Principal Investigators. Amongst other honours, Dr. McInnes is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences, and was the recipient of an honourary Doctor of Laws from Dalhousie University in 2007. He was appointed to the Order of Ontario in 2008, and a member of the Order of Canada in 2009. In 2010, Dr. McInnes was the President of the American Society of Human Genetics.